Source:http://linkedlifedata.com/resource/pubmed/id/17223345
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3-5
|
pubmed:dateCreated |
2007-3-19
|
pubmed:abstractText |
1,25(OH)(2)D(3) and 25(OH)D(3) have been associated with type 1 diabetes. Diverse enzymes are involved in the synthesis of these metabolites: the 25-Vitamin-D-hydroxylase (CYP2R1), the 25-hydroxyvitamin-D(3)-1-alpha-hydroxylase (CYP27B1) and the 25(OH)D(3)-24-hydroxylase (CYP24) among others. Serum levels of 25(OH)D(3) and 1,25(OH)(2)D(3) were investigated in type 1 diabetes patients (n=173) and the mRNA expression of the CYP2R1, CYP27B1 and CYP24 genes in type 1 diabetes patients (n=33) and healthy controls (n=23). These parameters were correlated with the -1260 (C/A) polymorphism in the CYP27B1 gene. Lower expression of CYP27B1 mRNA in comparison with healthy controls (1.7165 versus 1.7815, P=0.0268) was found. Additionally, patients carrying the genotype CC possessed a reduced amount of CYP27B1 mRNA compared to healthy controls (1.6855 versus 1.8107, respectively, P=0.0220). The heterozygosity rate of the -1260 C/A polymorphism was more frequent in patients with normal levels of 1,25(OH)(2)D(3) (> or =19.9 pmol/ml) than in whose with a level of less than 19.9 pmol/ml (46.7% versus 22.2%, P=0.0134). No correlation with serum levels of 25(OH)D(3) was found. Thus, CYP27B1 gene could play a functional role in the pathogenesis of type 1 diabetes through modulation of its mRNA expression and influence serum levels of 1,25(OH)(2)D(3) via the -1260 C/A polymorphism.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/25-Hydroxyvitamin D3...,
http://linkedlifedata.com/resource/pubmed/chemical/CYP2R1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 CYP27A1,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Steroid Hydroxylases,
http://linkedlifedata.com/resource/pubmed/chemical/vitamin D 24-hydroxylase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0960-0760
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
103
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
807-10
|
pubmed:dateRevised |
2008-8-16
|
pubmed:meshHeading |
pubmed-meshheading:17223345-25-Hydroxyvitamin D3 1-alpha-Hydroxylase,
pubmed-meshheading:17223345-Cytochrome P-450 CYP27A1,
pubmed-meshheading:17223345-Diabetes Mellitus, Type 1,
pubmed-meshheading:17223345-Gene Expression Regulation, Enzymologic,
pubmed-meshheading:17223345-Germany,
pubmed-meshheading:17223345-Humans,
pubmed-meshheading:17223345-RNA, Messenger,
pubmed-meshheading:17223345-Steroid Hydroxylases
|
pubmed:year |
2007
|
pubmed:articleTitle |
CYP2R1-, CYP27B1- and CYP24-mRNA expression in German type 1 diabetes patients.
|
pubmed:affiliation |
Department of Internal Medicine I, Division of Endocrinology, Diabetes and Metabolism, University Hospital Frankfurt, Theodor-Stern-Kai 7, D-60590 Frankfurt am Main, Germany.
|
pubmed:publicationType |
Journal Article
|